BlackRock Technology and Private Equity Term Trust (BTX)vsKKR & Co. Inc. (KKR)
BTX
BlackRock Technology and Private Equity Term Trust
$8.58
+2.26%
FINANCIAL SERVICES · Cap: $994.37M
KKR
KKR & Co. Inc.
$102.81
-0.52%
FINANCIAL SERVICES · Cap: $100.90B
Smart Verdict
WallStSmart Research — data-driven comparison
KKR leads profitability with a 12.4% profit margin vs 0.0%. BTX trades at a lower P/E of 23.0x. KKR earns a higher WallStSmart Score of 62/100 (C+).
BTX
Avoid26
out of 100
Grade: F
KKR
Buy62
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Large-cap with strong market position
Growing faster than its price suggests
Earnings expanding 42.7% YoY
Generating 1.9B in free cash flow
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Premium valuation, high expectations priced in
2.2% revenue growth
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BTX
BTX has a balanced fundamental profile.
Bull Case : KKR
The strongest argument for KKR centers on Market Cap, PEG Ratio, EPS Growth. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bear Case : BTX
The primary concerns for BTX are Revenue Growth, EPS Growth, Market Cap.
Bear Case : KKR
The primary concerns for KKR are P/E Ratio, Revenue Growth, Debt/Equity. Debt-to-equity of 1.80 is elevated, increasing financial risk.
Key Dynamics to Monitor
KKR is growing revenue faster at 2.2% — sustainability is the question.
KKR generates stronger free cash flow (1.9B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
KKR scores higher overall (62/100 vs 26/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Technology and Private Equity Term Trust
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Visit Website →KKR & Co. Inc.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
KKR & Co. Inc. is a leading global investment firm established in 1976, with a strong focus on private equity, credit, and real asset investments. The firm excels at identifying complex market opportunities and utilizes its extensive industry knowledge and global network to create sustainable long-term value across its portfolio. KKR is recognized for its commitment to sustainable investing, seamlessly integrating environmental, social, and governance (ESG) principles into its investment approach, thereby promoting responsible growth alongside financial performance. With a strategic emphasis on innovation and operational excellence, KKR remains a crucial player in the financial sector worldwide.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?